The Blood and Marrow Transplant and Cellular Therapies Program in collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, has been performing autologous and allogeneic stem cell transplants since 1995 and is the only such program in New Jersey that is part of an NCI-designated Comprehensive Cancer Center. Transplants are performed for patients with a variety of illnesses, including acute and chronic leukemias, myelodysplasia, various types of lymphoma, Hodgkin's disease, multiple myeloma, amyloidosis and related diseases. Our skilled team of hematologist/oncologists, advanced practice nurses, bone marrow transplant coordinators, oncology nurse navigators, and social workers come together to make sure their patients have the best care, tailored to individual needs.
Blood and marrow transplants and follow-up care are coordinated with the patient and referring physician, and when appropriate the follow-up care take place locally. Patients can be seen at Rutgers Cancer Institute in New Brunswick or at Cooperman Barnabas Medical Center, an RWJBarnabas Health facility, in Livingston as part of the Blood and Marrow Transplant Consult Clinic.
The Blood and Marrow Transplant and Cellular Therapies Program has a strong working relationship with the National Marrow Donor Program and is accredited by the National Marrow Donor Program and the Foundation for the Accreditation of Cellular Therapy (FACT). The program is rated as an “Excellent Program” by the American College of Surgeons.
Clinicians in the Blood and Marrow Transplant and Cellular Therapies Program focus on novel ways to prevent graft-versus-host disease; improve umbilical cord blood transplants; and develop cellular therapies with less toxicity than standard transplants. And our Oncology Nurse Navigators and transplant coordinators help guide patients through their cancer journey by coordinating care, answering questions, and serving as an important member of their care team.